Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 1Sarcoma 1Genitourinary 1

Conditions

Testicular Neoplasms 5Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Testicular Germ Cell Tumor 4Seminoma 3Ovarian Neoplasms 3Endodermal Sinus Tumor 3Central Nervous System Neoplasms 3Urethral Neoplasms 2Teratoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Embryonal 2Wilms Tumor 1Ureteral Neoplasms 1Stomach Neoplasms 1Renal Pelvis and Ureter Urothelial Carcinoma 1Pancreatic Neoplasms 1Pain 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Melanoma 1Kidney Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Dysgerminoma 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

Docetaxel 35pembrolizumab 32Nivolumab 27enzalutamide 20Prednisone 20Sunitinib 16Cyclophosphamide 16aldesleukin 14Zoledronic Acid 13Interleukin-2 13Gemcitabine 13Bevacizumab 13Specimen Handling 12Ipilimumab 12Radiosurgery 11Everolimus 11Androgen Antagonists 11Abiraterone Acetate 11fludarabine 10Sorafenib 10Radiotherapy 10Paclitaxel 10Magnetic Resonance Spectroscopy 10pazopanib 9abiraterone 9Doxorubicin 8Carboplatin 8Biopsy 8avelumab 7temsirolimus 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × pegfilgrastim × Genitourinary × Clear all
NCT01385228 2018-06-06

Pazopanib, Docetaxel, Prednisone Prostate

Duke University

Phase 1 Completed
36 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡